Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctioncalcium ion binding

EGFL8 CD93 LRP4 NID2 SVEP1 EYS NOTCH3

7.45e-06749217GO:0005509
GeneOntologyMolecularFunctioncell adhesion molecule binding

NRXN2 TNR SVEP1 NOTCH3

3.20e-03599214GO:0050839
GeneOntologyBiologicalProcesspostsynaptic membrane assembly

NRXN2 LRP4

5.94e-0511222GO:0097104
GeneOntologyBiologicalProcessneuron cell-cell adhesion

NRXN2 TNR

1.29e-0416222GO:0007158
GeneOntologyCellularComponentprotein complex involved in cell-matrix adhesion

LAMA2 TNR

1.30e-0417212GO:0098637
GeneOntologyCellularComponentextracellular matrix

LAMA2 TNR NID2 SVEP1 EYS

4.02e-04656215GO:0031012
GeneOntologyCellularComponentexternal encapsulating structure

LAMA2 TNR NID2 SVEP1 EYS

4.07e-04658215GO:0030312
GeneOntologyCellularComponentcell surface

EGFL8 CD93 LRP4 TNR NID2 NOTCH3

6.05e-041111216GO:0009986
GeneOntologyCellularComponentprotein complex involved in cell adhesion

LAMA2 TNR

1.59e-0359212GO:0098636
GeneOntologyCellularComponentcollagen-containing extracellular matrix

LAMA2 TNR NID2 EYS

1.73e-03530214GO:0062023
GeneOntologyCellularComponentneuromuscular junction

LAMA2 LRP4

5.59e-03112212GO:0031594
GeneOntologyCellularComponentbasement membrane

LAMA2 NID2

6.60e-03122212GO:0005604
HumanPhenoCraniofacial hyperostosis

LRP4 PLEKHM1 NOTCH3

2.09e-053883HP:0004493
HumanPhenoThickened calvaria

LRP4 PLEKHM1 NOTCH3

2.45e-054083HP:0002684
HumanPhenoCranial hyperostosis

LRP4 PLEKHM1 NOTCH3

5.74e-055383HP:0004437
HumanPhenoIncreased skull ossification

LRP4 PLEKHM1 NOTCH3

7.54e-055883HP:0004330
HumanPhenoHyperostosis

LRP4 PLEKHM1 NOTCH3

8.77e-056183HP:0100774
MousePhenoabnormal vertebral column morphology

LAMA2 LRP4 TRIM45 FAM221A PLEKHM1 NOTCH3

1.01e-04787156MP:0004703
MousePhenoabnormal osteocyte morphology

LRP4 NOTCH3

1.12e-0415152MP:0008753
MousePhenoabnormal osteocyte lacunocanalicular system morphology

LRP4 NOTCH3

1.63e-0418152MP:0030485
MousePhenoabnormal trabecular bone volume

LRP4 PLEKHM1 NOTCH3

2.18e-04113153MP:0010877
MousePhenodecreased bone trabecular spacing

LRP4 PLEKHM1

2.93e-0424152MP:0013631
MousePhenoabnormal spine curvature

LAMA2 LRP4 FAM221A NOTCH3

2.94e-04318154MP:0004174
MousePhenoabnormal bone trabecula morphology

LRP4 PLEKHM1 NOTCH3

3.60e-04134153MP:0010867
MousePhenoabnormal trabecular bone connectivity density

LRP4 NOTCH3

3.71e-0427152MP:0010931
MousePhenoabnormal skeleton physiology

LAMA2 LRP4 NID2 PLEKHM1 NOTCH3

3.82e-04632155MP:0001533
MousePhenoabnormal osteoblast morphology

LRP4 PLEKHM1 NOTCH3

3.84e-04137153MP:0004986
MousePhenoincreased bone ossification

LRP4 NOTCH3

5.23e-0432152MP:0020039
MousePhenodecreased nerve conduction velocity

LAMA2 TNR

7.39e-0438152MP:0008814
MousePhenoabnormal bone volume

LRP4 PLEKHM1 NOTCH3

7.60e-04173153MP:0010874
MousePhenotrunk curl

NRXN2 NSD3

1.04e-0345152MP:0001512
MousePhenoabnormal bone trabecular spacing

LRP4 PLEKHM1

1.18e-0348152MP:0013629
DomainEGF

EGFL8 NRXN2 LAMA2 CD93 LRP4 TNR NID2 MEGF11 SVEP1 EYS NOTCH3

3.12e-162352111SM00181
DomainEGF-like_dom

EGFL8 NRXN2 LAMA2 CD93 LRP4 TNR NID2 MEGF11 SVEP1 EYS NOTCH3

5.95e-162492111IPR000742
DomainEGF-like_CS

EGFL8 NRXN2 LAMA2 CD93 LRP4 TNR NID2 MEGF11 SVEP1 EYS NOTCH3

1.00e-152612111IPR013032
DomainEGF_2

EGFL8 NRXN2 LAMA2 CD93 LRP4 TNR NID2 MEGF11 SVEP1 EYS NOTCH3

1.19e-152652111PS01186
DomainEGF_3

EGFL8 NRXN2 CD93 LRP4 TNR NID2 MEGF11 SVEP1 EYS NOTCH3

2.57e-142352110PS50026
DomainEGF

EGFL8 NRXN2 CD93 LRP4 NID2 SVEP1 EYS NOTCH3

6.48e-13126218PF00008
DomainEGF_1

EGFL8 NRXN2 LAMA2 LRP4 TNR MEGF11 SVEP1 EYS NOTCH3

3.65e-12255219PS00022
DomainEGF_Ca-bd_CS

EGFL8 CD93 LRP4 NID2 SVEP1 EYS NOTCH3

8.96e-1297217IPR018097
DomainEGF_CA

EGFL8 CD93 LRP4 NID2 SVEP1 EYS NOTCH3

1.04e-1199217PS01187
DomainASX_HYDROXYL

EGFL8 CD93 LRP4 NID2 SVEP1 EYS NOTCH3

1.11e-11100217PS00010
DomainEGF-type_Asp/Asn_hydroxyl_site

EGFL8 CD93 LRP4 NID2 SVEP1 EYS NOTCH3

1.69e-11106217IPR000152
DomainEGF_CA

EGFL8 CD93 LRP4 NID2 SVEP1 EYS NOTCH3

4.60e-11122217SM00179
DomainEGF-like_Ca-bd_dom

EGFL8 CD93 LRP4 NID2 SVEP1 EYS NOTCH3

5.16e-11124217IPR001881
DomainEGF_CA

EGFL8 CD93 LRP4 NID2 SVEP1 NOTCH3

4.10e-1086216PF07645
DomainGrowth_fac_rcpt_

CD93 LRP4 NID2 SVEP1 EYS NOTCH3

1.51e-08156216IPR009030
DomainhEGF

MEGF11 SVEP1 EYS NOTCH3

2.38e-0828214PF12661
DomainEGF_extracell

TNR MEGF11 SVEP1 NOTCH3

5.53e-0760214IPR013111
DomainEGF_2

TNR MEGF11 SVEP1 NOTCH3

5.53e-0760214PF07974
DomaincEGF

CD93 LRP4 NID2

3.13e-0626213IPR026823
DomaincEGF

CD93 LRP4 NID2

3.13e-0626213PF12662
Domain-

NRXN2 LAMA2 SVEP1 EYS

3.52e-06952142.60.120.200
DomainLAM_G_DOMAIN

NRXN2 LAMA2 EYS

1.01e-0538213PS50025
DomainLaminin_G_2

NRXN2 LAMA2 EYS

1.18e-0540213PF02210
DomainLamG

NRXN2 LAMA2 EYS

1.58e-0544213SM00282
DomainLaminin_G

NRXN2 LAMA2 EYS

3.63e-0558213IPR001791
DomainLaminin_G_1

LAMA2 EYS

6.58e-0511212PF00054
Domain-

NID2 SVEP1

6.58e-05112122.40.155.10
DomainGFP-like

NID2 SVEP1

6.58e-0511212IPR023413
DomainConA-like_dom

NRXN2 LAMA2 SVEP1 EYS

9.41e-05219214IPR013320
DomainLdl_recept_b

LRP4 NID2

1.09e-0414212PF00058
DomainLDLRB

LRP4 NID2

1.09e-0414212PS51120
DomainLY

LRP4 NID2

1.25e-0415212SM00135
DomainLDLR_classB_rpt

LRP4 NID2

1.25e-0415212IPR000033
DomainEMI_domain

EGFL8 MEGF11

1.43e-0416212IPR011489
DomainEMI

EGFL8 MEGF11

1.62e-0417212PS51041
DomainLaminin_EGF

LAMA2 MEGF11

7.01e-0435212PF00053
DomainEGF_Lam

LAMA2 MEGF11

7.01e-0435212SM00180
DomainLaminin_EGF

LAMA2 MEGF11

8.26e-0438212IPR002049
Domain-

LRP4 NID2

8.70e-04392122.120.10.30
Domain6-blade_b-propeller_TolB-like

LRP4 NID2

1.21e-0346212IPR011042
PathwayREACTOME_ECM_PROTEOGLYCANS

LAMA2 LRP4 TNR

6.54e-0576153M27219
PathwayREACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION

LAMA2 LRP4 TNR NID2

2.28e-04300154M610
PathwayREACTOME_LAMININ_INTERACTIONS

LAMA2 NID2

4.52e-0430152M27216
Pubmed

Binding of the G domains of laminin alpha1 and alpha2 chains and perlecan to heparin, sulfatides, alpha-dystroglycan and several extracellular matrix proteins.

LAMA2 NID2

2.29e-06422210022829
Pubmed

A synaptic nidogen: developmental regulation and role of nidogen-2 at the neuromuscular junction.

LAMA2 NID2

5.72e-06622218817539
Pubmed

Basement membrane composition in the early mouse embryo day 7.

LAMA2 NID2

3.99e-051522215895400
Pubmed

Basement membrane assembly of the integrin α8β1 ligand nephronectin requires Fraser syndrome-associated proteins.

LAMA2 NID2

1.53e-042922222613833
Pubmed

Protein interactome reveals converging molecular pathways among autism disorders.

FAM221A MEGF11 PLEKHM1 NOTCH3

3.86e-0456022421653829
Pubmed

Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c.

LAMA2 NID2 SVEP1

4.99e-0424822324006456
InteractionZNF74 interactions

LRP4 ZNF74 NOTCH3

5.72e-0634213int:ZNF74
InteractionIGSF5 interactions

LRP4 NOTCH3

9.34e-0514212int:IGSF5
InteractionZNF224 interactions

LRP4 NOTCH3

1.94e-0420212int:ZNF224
InteractionMAML3 interactions

NID2 NOTCH3

1.94e-0420212int:MAML3
InteractionJAG2 interactions

ZNF74 NOTCH3 STS

1.96e-04110213int:JAG2
InteractionNTN5 interactions

LRP4 NOTCH3

2.82e-0424212int:NTN5
CoexpressionNABA_ECM_GLYCOPROTEINS

LAMA2 TNR NID2 SVEP1 EYS

4.10e-07196215M3008
CoexpressionNABA_CORE_MATRISOME

LAMA2 TNR NID2 SVEP1 EYS

2.17e-06275215M5884
CoexpressionHOEK_MYELOID_DENDRITIC_CELL_2011_2012_TIV_ADULT_1DY_DN

NRXN2 NOTCH3

9.15e-066212M41153
CoexpressionNABA_MATRISOME

EGFL8 LAMA2 TNR NID2 MEGF11 SVEP1 EYS

9.91e-061026217M5889
CoexpressionNABA_ECM_GLYCOPROTEINS

LAMA2 TNR NID2 SVEP1

1.48e-05191214MM17059
CoexpressionNABA_CORE_MATRISOME

LAMA2 TNR NID2 SVEP1

5.74e-05270214MM17057
CoexpressionNABA_MATRISOME

EGFL8 LAMA2 TNR NID2 MEGF11 SVEP1

1.05e-041008216MM17056
CoexpressionDESCARTES_FETAL_EYE_HORIZONTAL_CELLS

TNR MEGF11

1.40e-0422212M40179
CoexpressionFAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_ENDOTHELIAL

LAMA2 CD93 NID2 NOTCH3

1.84e-04365214M39018
CoexpressionCHYLA_CBFA2T3_TARGETS_UP

CD93 TRIM45 SLCO4A1 NOTCH3

2.32e-04388214M2205
CoexpressionCHIARETTI_T_ALL_REFRACTORY_TO_THERAPY

NID2 NOTCH3

2.62e-0430212M10778
CoexpressionCHYLA_CBFA2T3_TARGETS_UP

CD93 TRIM45 SLCO4A1 NOTCH3

2.68e-04403214MM1060
CoexpressionDESCARTES_FETAL_LIVER_STELLATE_CELLS

LAMA2 NID2 SVEP1

2.74e-04160213M40233
CoexpressionGSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_2H_DN

NRXN2 TNR GK

4.06e-04183213M4289
CoexpressionNOTCH_DN.V1_DN

LRP4 ZNF74 NOTCH3

4.06e-04183213M2788
CoexpressionNABA_BASEMENT_MEMBRANES

LAMA2 NID2

4.68e-0440212M5887
CoexpressionGSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_6H_DN

CD93 ZNF74 STS

4.89e-04195213M8160
CoexpressionGSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_40H_TSST_ACT_UP

CD93 TRIM45 ZNF646

4.89e-04195213M5318
CoexpressionGSE2585_CD80_HIGH_VS_LOW_AIRE_KO_MTEC_DN

TRIM45 TNR GK

5.18e-04199213M6275
CoexpressionGSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP

CD93 LRP4 NSD3

5.26e-04200213M8630
CoexpressionGSE13738_RESTING_VS_TCR_ACTIVATED_CD4_TCELL_DN

SLCO4A1 FAM221A GK

5.26e-04200213M3320
CoexpressionGSE31622_WT_VS_KLF3_KO_BCELL_UP

FAM221A SVEP1 NOTCH3

5.26e-04200213M8473
CoexpressionGSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_MAC_DN

TNR NID2 SVEP1

5.26e-04200213M5167
CoexpressionDESCARTES_MAIN_FETAL_HORIZONTAL_CELLS

TNR MEGF11

6.47e-0447212M40096
ToppCellPND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

NRXN2 LAMA2 LRP4 NID2 NOTCH3

2.79e-081952157a32a8535c29b819dacba901d0658280a2631c94
ToppCellPND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

NRXN2 LAMA2 LRP4 NID2 NOTCH3

2.79e-081952154a5d2f62aad5817d077177bf8b4ff0e46d3b8d97
ToppCellPND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

LAMA2 LRP4 NID2 NOTCH3

1.20e-06173214cbd65dd5b01cc959e3ccbc89330ddd0122296ea3
ToppCellPND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

LAMA2 LRP4 NID2 NOTCH3

1.20e-06173214f9d6e892d66f9b94e4d5beb9f5dec9b606bc868a
ToppCell356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells)

NRXN2 LAMA2 NID2 SVEP1

1.32e-06177214cdfd2f0ee2f692271b1525e414b0f645cdadb1f6
ToppCell356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells)

NRXN2 LAMA2 NID2 SVEP1

1.32e-06177214db222faaecbe5600da39277243c4e7e764eb63c9
ToppCellNon-neuronal-Postmitotic-Mural|World / Primary Cells by Cluster

LAMA2 CD93 NID2 NOTCH3

2.05e-06198214dd38840a96171f58da243daa22b013e15a81db4a
ToppCellNon-neuronal-Postmitotic-Mural-Mural|World / Primary Cells by Cluster

LAMA2 CD93 NID2 NOTCH3

2.05e-061982149fc1035ea447a4551a66944c869c4671e17cec61
ToppCellNon-neuronal-Postmitotic-Mural-Mural-18|World / Primary Cells by Cluster

LAMA2 CD93 NID2 NOTCH3

2.05e-0619821421efb7bcd24f24d20791b34e75d6f9d46a129481
ToppCellNon-neuronal-Postmitotic-Endothelial|World / Primary Cells by Cluster

LAMA2 CD93 NID2 NOTCH3

2.10e-06199214b9763ac9857a60db6f1f104fe1e9ea2266cf931b
ToppCellNon-neuronal-Postmitotic-Endothelial-Endothelial-24|World / Primary Cells by Cluster

LAMA2 CD93 NID2 NOTCH3

2.10e-061992140b4edf3e359749827ef978a77b5267ddde732d71
ToppCellNon-neuronal-Postmitotic-Endothelial-Endothelial|World / Primary Cells by Cluster

LAMA2 CD93 NID2 NOTCH3

2.10e-061992149e01eee126247a0696c71b019f855a8a41a0ede3
ToppCellcellseq2-Mesenchymal-Fibroblastic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

NRXN2 LAMA2 NID2 SVEP1

2.14e-062002141c10597edd532bf172ca09870a937d35e2585081
ToppCellcellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

NRXN2 LAMA2 NID2 SVEP1

2.14e-06200214440dda48b09c6a8581b7ca634b0d67f1ecacf65e
ToppCellcellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

NRXN2 LAMA2 NID2 SVEP1

2.14e-0620021444317fbf4d1480a37b50ab2777bf1a3e4fc0c05f
ToppCellCOVID-19-kidney-Mito-rich_Int|kidney / Disease (COVID-19 only), tissue and cell type

LAMA2 SVEP1 EYS

2.95e-0512921357b705106aec7bbfc587de1ccd4f2335fc44dd6f
ToppCell10x5'-bone_marrow-Lymphocytic_Invariant-Inducer-like-ILC3|bone_marrow / Manually curated celltypes from each tissue

TRIM45 TNR ZNF646

5.10e-0515521383430a64c2cb5ad29caa3dacba76c28dd204ac40
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

LAMA2 NID2 NOTCH3

5.39e-0515821332c95c1bc9e50fccd6d06e828f29258fc5e568cb
ToppCellTCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Diffuse-3|TCGA-Stomach / Sample_Type by Project: Shred V9

NRXN2 LAMA2 SVEP1

6.36e-05167213d2230c894ccf9dbba9196e079ae81f384d43da63
ToppCell356C-Fibroblasts-Fibroblast-H|356C / Donor, Lineage, Cell class and subclass (all cells)

NID2 SVEP1 NOTCH3

6.47e-05168213838ce47d4958ba12047882f97925eddd02f081c7
ToppCell356C-Fibroblasts-Fibroblast-H-|356C / Donor, Lineage, Cell class and subclass (all cells)

NID2 SVEP1 NOTCH3

6.47e-05168213b5d74500bdac0d680ce7eb7afa0b867b8d85e6a4
ToppCelldroplet-Spleen-nan-21m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NRXN2 SLCO4A1 NOTCH3

6.59e-051692137962165cab84af73d20b56eb70b1ed87c94025ef
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

LAMA2 NID2 SVEP1

6.70e-05170213fa753cc8fbd04e63c9a303da4dc17ee2ce907f92
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

LAMA2 NID2 SVEP1

6.70e-0517021303044e1436443b28dd39d5ef4fdb25c18e3a7546
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

LAMA2 TRIM45 SVEP1

6.82e-051712132a34685f7d83d1cf9a88d304173cbca868c5f9fd
ToppCellControl-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations)

LAMA2 NID2 NOTCH3

6.82e-05171213080003f698f867935c2bfc55d241d3650f45a0ab
ToppCellPND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CD93 TNR FAM221A

7.06e-0517321312f779b8dce79431b2d1002ba524dd3f9566aeb0
ToppCelldroplet-Lung-30m-Hematologic-myeloid-plasmacytoid_dendritic_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

NRXN2 SLCO4A1 NOTCH3

7.06e-051732134f0c065e876197ad8cae7856669f09e37ecafa3f
ToppCell-Donor_08|World / lung cells shred on cell class, cell subclass, sample id

LAMA2 NID2 SVEP1

7.06e-0517321388be9182fbb1bc83531cd41e59ea57c112a21d54
ToppCelldroplet-Lung-30m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

NRXN2 SLCO4A1 NOTCH3

7.06e-051732139bbea566964281f47bf75d665b7d69ba8326e207
ToppCellfacs-Brain_Non-Myeloid-Cortex-24m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NRXN2 TNR MEGF11

7.31e-051752131d1cdbf3221b03e24eae38afd57cbd6736b37a53
ToppCellfacs-Brain_Non-Myeloid-Cortex-24m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NRXN2 TNR MEGF11

7.31e-05175213d67c77eee979ad029e7545f383326f0ff77c6e5f
ToppCell(0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells|World / Stress and Cell class

LRP4 NID2 NOTCH3

7.43e-05176213ce2c32b5ce0da848eb4da35ce4d215cdf74d9113
ToppCellfacs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NRXN2 LAMA2 SVEP1

7.43e-05176213f25251abd4ef9fb077a978f9f9f658af58e4e0d2
ToppCellkidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CD93 SLCO4A1 ZNF74

7.43e-051762131df7b6ce2519ad99bacbbaf1a8d5929e11513faa
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_26.46.91|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

NRXN2 TRIM45 NOTCH3

7.43e-0517621329b71369503719c74888cd356ceb6724cfdcabd9
ToppCell343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells)

NRXN2 LAMA2 SVEP1

7.43e-051762132e94bbe17c0bb65dc58b4ebc0cb829258bd7373b
ToppCell343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells)

NRXN2 LAMA2 SVEP1

7.43e-05176213f33ab41d121b59d871ad7d48ca021524a027d2ef
ToppCellfacs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NRXN2 LAMA2 SVEP1

7.43e-05176213fee4e0f32aaf77294040c7af6c1f503571750d43
ToppCelldroplet-Lung-nan-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LRP4 NID2 NOTCH3

7.56e-0517721365709bd546cb1ec6aa2ddd8b2adb46e174eb9a9a
ToppCelldroplet-Lung-nan-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LRP4 NID2 NOTCH3

7.56e-051772138684d47a547e2a06496f15e8da0200ecddc431e0
ToppCellEndothelial-A-IPF_04|World / lung cells shred on cell class, cell subclass, sample id

EGFL8 NRXN2 CD93

7.68e-051782132f2602b9305d55f25afa9861dd6c6347ae179337
ToppCell10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

LRP4 SVEP1 NOTCH3

7.68e-05178213e32f5ed7a492edfa7073416008b1fcfae6b854ad
ToppCellfacs-Lung-nan-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LAMA2 NID2 NOTCH3

7.81e-051792137078022e60faa86444f2a2c6eb9f767cc66b5cfa
ToppCell-Donor_02|World / lung cells shred on cell class, cell subclass, sample id

LAMA2 NID2 SVEP1

7.81e-0517921310fadbaa1b6d21cbf9f354d717cc4c225619f4fd
ToppCellfacs-Lung-nan-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LAMA2 NID2 NOTCH3

7.81e-05179213d4a975d8ffa5e77fb5c0ec05bf9c8f843c77ce07
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

LAMA2 NID2 NOTCH3

7.94e-0518021364956a85c404a2ea7e4eaf6f95ebcc52c198b7cc
ToppCellPCW_05-06-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

EGFL8 CD93 EYS

7.94e-051802135861b44acfb8fe92c281c8355bf19c059b3dcd64
ToppCellEndothelial-A-HP_01|World / lung cells shred on cell class, cell subclass, sample id

CD93 TNR SLCO4A1

7.94e-051802134c3376169770ee9f9283daae44c17f35e46bfd19
ToppCellfacs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NRXN2 LRP4 TNR

8.07e-051812131037051eb82313c13346617b33f3c4c648181c4d
ToppCell5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LAMA2 LRP4 TRIM45

8.07e-05181213b116c68393d8836bac080f81a8fcbeb52e0403e7
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

LAMA2 NID2 SVEP1

8.07e-05181213c62b0a2422377ffadaab63edd538e87a06fa5017
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

LAMA2 NID2 SVEP1

8.07e-05181213c6d2a13df3b74fade3b0c71e285b4c14c8e52413
ToppCellPrimary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

LRP4 TNR MEGF11

8.21e-05182213831b5ce46b41efe01c4db6016c2f43148611373d
ToppCellAnterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

LRP4 TNR MEGF11

8.21e-051822133cc61f5f7ad4a81eba3daf65e122880b5af3adc0
ToppCellSomatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

LRP4 TNR MEGF11

8.21e-051822138a8b08ac4bb3cba3541dbe234e088703842285b9
ToppCellAnterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

LRP4 TNR MEGF11

8.21e-051822135d909e4b5f662905bf1be9c686bbddc3e87d2be9
ToppCellCOVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type

LAMA2 NID2 SVEP1

8.21e-05182213fbd5e332df73bf7141c822fa67b76367dc962017
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

LAMA2 NID2 NOTCH3

8.21e-05182213fc4a5bf784705efe7965ce43ac23c2a8e602e90a
ToppCellSomatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

LRP4 TNR MEGF11

8.21e-05182213e36766309c4d96a90d213ce37d3acef1029a3fdc
ToppCellPrimary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

LRP4 TNR MEGF11

8.21e-05182213a05e5978ef5f7fac7eeb2ba1c0103ea90d5e9136
ToppCellfacs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NRXN2 TNR MEGF11

8.48e-051842138d86e125257ff1d3af8d90577a8b3f0321eca21c
ToppCelldroplet-Lung-1m-Mesenchymal-myofibroblast-pericyte_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

LAMA2 NID2 NOTCH3

8.48e-0518421339bb0eb55bdc2cea46e41c7f21d8c5883f14e6bd
ToppCellTCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9

LAMA2 CD93 SVEP1

8.48e-0518421367164bb6bcae7322cb89b585c7aa10bce35b0ecd
ToppCelldroplet-Lung-1m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

LAMA2 NID2 NOTCH3

8.48e-051842134cb5f299dd7413e0be1ad7af817ee614b23a18ae
ToppCellfacs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NRXN2 TNR MEGF11

8.48e-05184213278a7ed764c326450cb70e69ed2175980eaf5fe0
ToppCellprimary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

LRP4 TNR MEGF11

8.61e-05185213efc5d564f8793c751ba640aef60f761e4b081d3f
ToppCellMid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

LRP4 TNR MEGF11

8.61e-051852137aaa8335b40927e3e8fdcede807cd521fc213a0d
ToppCellfacs-Thymus-Epithelium-24m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NRXN2 LRP4 SVEP1

8.61e-05185213eaa54b76743628c89b4310be57b87fa92b75fd37
ToppCellfacs-Thymus-Epithelium-24m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NRXN2 LRP4 SVEP1

8.61e-05185213f7f4c921d248c637351e2e882589b99ba7f04b66
ToppCellprimary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

LRP4 TNR MEGF11

8.61e-05185213fba2dc46cd98ab9c78e788959c2121aa10d148b2
ToppCellfacs-Thymus-Epithelium-24m-Mesenchymal|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NRXN2 LRP4 SVEP1

8.61e-05185213ff38a15af3dec36d9993f06623591872b5d1da9a
ToppCellMid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

LRP4 TNR MEGF11

8.61e-051852132e1766f1a972fecd670daaaf7eb2d3a404f121e7
ToppCellTCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-2|TCGA-Kidney / Sample_Type by Project: Shred V9

CD93 NID2 NOTCH3

8.75e-051862131e6526fc9e9381b7ace864588cc7bd80194338d6
ToppCellP15-Mesenchymal-developing_mesenchymal_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

LAMA2 NID2 NOTCH3

8.75e-05186213db9b67066fc003c7995ec205d15176bf40c97add
ToppCelldroplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LAMA2 TNR SVEP1

8.75e-0518621394d577dbb6bfacf50632e1fe8af041b35a1e6b23
ToppCell5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.4.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

NRXN2 LAMA2 SVEP1

8.75e-0518621307d94d5d1c2fe7bb909a07ca81058a0eabc65c60
ToppCellPrimary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

LRP4 TNR MEGF11

8.89e-05187213daff7ccd3f1924cf2b34d3aca3eccde245aaf371
ToppCell356C-Lymphocytic-CD4_T-cell-Treg_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

SLCO4A1 FAM221A GK

8.89e-05187213c8278525b3e1d3f3f4defcaf109cce22dd2e157a
ToppCellPrimary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

LRP4 TNR MEGF11

8.89e-051872135b7a1edee602e55d3400dc17dbb6b8aaa26defc0
ToppCellwk_15-18-Endothelial-Blood_vessel_endothelial-GRIA2+_arterial_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

EGFL8 CD93 EYS

9.03e-05188213366a2d59b9c81d8a7659749f9c07efa46b49a39a
ToppCell5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

NRXN2 LAMA2 SVEP1

9.03e-05188213e18065bbc26d6f3774fd1f478fb41d8fb555fa26
ToppCellfacs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NRXN2 TNR MEGF11

9.03e-05188213006db2c2c44971ca9241c582bc89f258c785f5ed
ToppCellkidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

EGFL8 CD93 SLCO4A1

9.03e-05188213a37edd8f9e4a4e336b5acbb0407d3d275975cee8
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

LAMA2 NID2 SVEP1

9.03e-05188213ce85a56ac27a6432421dde93a1bafa8b943244b9
ToppCell10x5'v1-week_12-13-Mesenchymal_osteo-stroma-chondrocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

NID2 SVEP1 NOTCH3

9.03e-05188213c9270517e6940e9793586f67f02431210552f278
ToppCellfacs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NRXN2 TNR MEGF11

9.03e-05188213d0e6fb4a3b3d79d3512b5500062ea285495ae526
ToppCellCOVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type

LAMA2 NID2 SVEP1

9.03e-05188213fe361215f4ba841aa5e1e581fb56f2f4d3ccd201
ToppCellfacs-Lung-18m-Mesenchymal-fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

LAMA2 LRP4 SVEP1

9.18e-0518921340cbd679dc0548bf5207e1b033c0597886ad6fe1
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

LAMA2 NID2 SVEP1

9.18e-0518921371397e993a77d70b2eeede240bdfc7660b558987
ToppCell5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

NRXN2 LAMA2 SVEP1

9.18e-05189213f7d57723b8fb0f1e1485f51e3eff93ec0f39761e
ToppCellfacs-Lung-EPCAM-24m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NRXN2 LRP4 SVEP1

9.18e-05189213324c81285c51f4f8bb1aef428b18fe2c549c2c11
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

LAMA2 NID2 SVEP1

9.18e-051892134eea4759520c312bd17a681034d8074e47093d2b
ToppCell356C-Lymphocytic-CD4_T-cell-Treg_cell_3|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)

SLCO4A1 FAM221A GK

9.18e-0518921399b01893da9f9f7c9528afaffad178285211738b
ToppCellfacs-Skin-nan-18m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NRXN2 LAMA2 SVEP1

9.18e-0518921329287525120be2953b76881ba3cfc4379c265e7a
ToppCellfacs-Skin-nan-18m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NRXN2 LAMA2 SVEP1

9.18e-051892137150dad9a92a715487c2d8130fa01b752ea69663
ToppCelldroplet-Lung-immune-endo-depleted|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LAMA2 LRP4 SVEP1

9.18e-05189213c3fb363bb0156ffb3367c200f548faebda64ab4a
ToppCellE18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass

LAMA2 LRP4 SVEP1

9.18e-051892130c18d3de4720759cf802eefb4d0ddde2a9246a1a
ToppCellfacs-Lung-18m-Mesenchymal|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

LAMA2 LRP4 SVEP1

9.18e-05189213bdf8db938aa0863c4fed6fa99dcffd63c8c20c31
ToppCelldroplet-Lung-immune-endo-depleted-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LAMA2 LRP4 SVEP1

9.18e-051892132a2953f6b1b7d070d739dcaf7285fce6e097d9e4
DrugMebendazole [31431-39-7]; Down 200; 13.6uM; PC3; HT_HG-U133A

TRIM45 ZNF74 NID2 STS

2.73e-051942143671_DN
DrugBenzthiazide [91-33-8]; Up 200; 9.2uM; PC3; HT_HG-U133A

LAMA2 CD93 NID2 STS

2.84e-051962146607_UP
Drugnifedipine; Up 200; 10uM; MCF7; HG-U133A

NID2 SVEP1 NOTCH3 ZNF646

2.90e-05197214335_UP
DrugNialamide [51-12-7]; Up 200; 13.4uM; PC3; HT_HG-U133A

CD93 LRP4 SVEP1 NOTCH3

2.96e-051982144525_UP
DrugBenzamil hydrochloride [2898-76-2]; Down 200; 11.2uM; PC3; HT_HG-U133A

SVEP1 NOTCH3 NSD3 STS

3.02e-051992144294_DN
Drugdehydroepiandrosterone sulfate

NRXN2 SLCO4A1 GK STS

1.09e-04277214CID000005244
DrugLinuron

NRXN2 NOTCH3 STS

2.14e-04128213ctd:D008044
Drugprocymidone

NRXN2 NOTCH3 STS

3.76e-04155213ctd:C035988
Drugestrone sulfate

NRXN2 SLCO4A1 STS

4.36e-04163213CID000000699
DrugDB04780

TNR NID2 STS

4.93e-04170213CID005459389
DrugPodophyllotoxin [518-28-5]; Up 200; 9.6uM; PC3; HT_HG-U133A

LRP4 NID2 STS

6.50e-041872135841_UP
DrugFluocinonide [356-12-7]; Up 200; 8uM; PC3; HT_HG-U133A

LAMA2 ZNF74 NSD3

6.81e-041902134314_UP
DrugCP-944629 [668990-94-1]; Down 200; 10uM; PC3; HT_HG-U133A

TRIM45 NID2 STS

6.91e-041912137549_DN
DrugPrednisolone [50-24-8]; Up 200; 11uM; PC3; HT_HG-U133A

NRXN2 LAMA2 LRP4

7.02e-041922135101_UP
DrugEnilconazole [35554-44-0]; Down 200; 13.4uM; HL60; HT_HG-U133A

LAMA2 NSD3 STS

7.13e-041932133139_DN
DrugTropicamide [1508-75-4]; Down 200; 14uM; PC3; HT_HG-U133A

SVEP1 NOTCH3 NSD3

7.13e-041932134280_DN
DrugHarmaline hydrochloride dihydrate [6027-98-1]; Up 200; 14uM; PC3; HT_HG-U133A

LAMA2 CD93 ZNF74

7.13e-041932136623_UP
DrugPrednicarbate [73771-04-7]; Down 200; 8.2uM; PC3; HT_HG-U133A

ZNF74 NSD3 STS

7.13e-041932135119_DN
DrugNovobiocin sodium salt [1476-53-5]; Up 200; 6.4uM; PC3; HT_HG-U133A

SVEP1 NOTCH3 NSD3

7.13e-041932134569_UP
DrugMetoclopramide monohydrochloride [7232-21-5]; Down 200; 11.8uM; PC3; HT_HG-U133A

LRP4 NOTCH3 STS

7.13e-041932134285_DN
DrugNadolol [42200-33-9]; Up 200; 13uM; PC3; HT_HG-U133A

LRP4 SVEP1 NOTCH3

7.23e-041942134021_UP
DrugCyclosporin A [59865-13-3]; Down 200; 3.4uM; MCF7; HT_HG-U133A

TRIM45 ZNF74 NOTCH3

7.23e-041942134411_DN
DrugPhenelzine sulfate [156-51-4]; Up 200; 17uM; PC3; HT_HG-U133A

LRP4 NSD3 STS

7.23e-041942134538_UP
DrugLomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; PC3; HT_HG-U133A

ZNF74 NSD3 STS

7.23e-041942134281_DN
DrugH-89, Dihydrochloride; Up 200; 0.5uM; PC3; HT_HG-U133A

ZNF74 NID2 STS

7.34e-041952136873_UP
DrugXamoterol hemifumarate [73210-73-8]; Up 200; 5uM; MCF7; HT_HG-U133A

LRP4 SVEP1 STS

7.34e-041952133401_UP
DrugOxamniquine [21738-42-1]; Up 200; 14.4uM; HL60; HT_HG-U133A

LAMA2 SVEP1 NOTCH3

7.34e-041952132924_UP
DrugDelcorine; Up 200; 8.4uM; MCF7; HT_HG-U133A

NRXN2 STS ZNF646

7.34e-041952133613_UP
DrugCarbamazepine [298-46-4]; Down 200; 17uM; PC3; HT_HG-U133A

SVEP1 NOTCH3 STS

7.34e-041952135093_DN
DrugCP-863187 [668981-07-5]; Up 200; 10uM; PC3; HT_HG-U133A

NOTCH3 NSD3 STS

7.45e-041962137512_UP
DrugFusaric acid [536-69-6]; Up 200; 22.4uM; PC3; HT_HG-U133A

LRP4 NSD3 STS

7.45e-041962133986_UP
DrugFluvoxamine maleate [61718-82-9]; Up 200; 9.2uM; MCF7; HT_HG-U133A

NOTCH3 NSD3 STS

7.45e-041962134114_UP
DrugTetracycline hydrochloride [64-75-5]; Down 200; 8.4uM; PC3; HT_HG-U133A

NID2 SVEP1 NOTCH3

7.45e-041962135757_DN
DrugPentetic acid [67-43-6]; Up 200; 10.2uM; MCF7; HT_HG-U133A

LAMA2 LRP4 STS

7.45e-041962133387_UP
DrugMuramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; PC3; HT_HG-U133A

SVEP1 NSD3 STS

7.45e-041962134582_UP
DrugLithocholic acid [434-13-9]; Down 200; 10.6uM; PC3; HT_HG-U133A

LAMA2 ZNF74 STS

7.45e-041962133816_DN
DrugRetrorsine [480-54-6]; Up 200; 11.4uM; PC3; HT_HG-U133A

ZNF74 STS ZNF646

7.45e-041962136601_UP
DrugNialamide [51-12-7]; Down 200; 13.4uM; PC3; HT_HG-U133A

LAMA2 NSD3 STS

7.45e-041962133790_DN
DrugPhthalylsulfathiazole [85-73-4]; Up 200; 10uM; MCF7; HT_HG-U133A

LRP4 STS ZNF646

7.45e-041962133371_UP
DrugMethimazole [60-56-0]; Up 200; 35uM; MCF7; HT_HG-U133A

LAMA2 CD93 STS

7.45e-041962134372_UP
DrugThyroxine (L) [51-48-9]; Up 200; 5.2uM; PC3; HT_HG-U133A

NRXN2 LAMA2 STS

7.56e-041972134069_UP
DrugTrichlorfon [52-68-6]; Up 200; 15.6uM; MCF7; HT_HG-U133A

NSD3 STS ZNF646

7.56e-041972131675_UP
Drug2-propylpentanoic acid; Up 200; 1000uM; PC3; HT_HG-U133A

CD93 NOTCH3 NSD3

7.56e-041972134433_UP
DrugXylazine [7361-61-7]; Down 200; 18.2uM; PC3; HT_HG-U133A

SVEP1 NOTCH3 STS

7.56e-041972134066_DN
DrugHesperidin [520-26-3]; Up 200; 6.6uM; PC3; HT_HG-U133A

NRXN2 SVEP1 STS

7.56e-041972136714_UP
DrugProchlorperazine dimaleate [84-02-6]; Up 200; 6.6uM; PC3; HT_HG-U133A

LRP4 ZNF74 SVEP1

7.56e-041972136664_UP
DrugPropidium iodide [25535-16-4]; Up 200; 6uM; PC3; HT_HG-U133A

NRXN2 LAMA2 ZNF646

7.56e-041972135803_UP
Drug9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A

TRIM45 ZNF74 STS

7.56e-041972137504_DN
DrugSulfamethizole [144-82-1]; Up 200; 14.8uM; HL60; HT_HG-U133A

ZNF74 STS ZNF646

7.68e-041982132536_UP
DrugTriamterene [396-01-0]; Up 200; 15.8uM; PC3; HT_HG-U133A

TRIM45 NSD3 STS

7.68e-041982137307_UP
DrugMegestrol acetate [595-33-5]; Down 200; 10.4uM; HL60; HT_HG-U133A

LAMA2 ZNF74 SVEP1

7.68e-041982133091_DN
DrugNiacin [59-67-6]; Up 200; 32.4uM; MCF7; HT_HG-U133A

LAMA2 LRP4 STS

7.68e-041982133381_UP
DrugMeclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; PC3; HT_HG-U133A

NOTCH3 NSD3 STS

7.68e-041982133707_DN
DrugHeptaminol hydrochloride [543-15-7]; Up 200; 22uM; PC3; HT_HG-U133A

LAMA2 NSD3 STS

7.68e-041982137313_UP
Drug0225151-0000 [351320-15-5]; Up 200; 10uM; PC3; HT_HG-U133A

TRIM45 NSD3 STS

7.68e-041982136426_UP
DrugCGX 0596987; Up 200; 20uM; PC3; HT_HG-U133A

TRIM45 NSD3 STS

7.68e-041982136369_UP
DrugTropicamide [1508-75-4]; Up 200; 14uM; PC3; HT_HG-U133A

CD93 NSD3 STS

7.68e-041982133722_UP
DrugPropranolol hydrochloride [318-98-9]; Up 200; 13.6uM; HL60; HT_HG-U133A

NRXN2 NOTCH3 ZNF646

7.68e-041982133059_UP
DrugPiperine [94-62-2]; Up 200; 14uM; MCF7; HT_HG-U133A

LAMA2 SVEP1 STS

7.68e-041982134830_UP
DrugVancomycin hydrochloride [1404-93-9]; Up 200; 2.6uM; MCF7; HT_HG-U133A

LAMA2 NOTCH3 ZNF646

7.79e-041992134423_UP
DrugPirenzepine dihydrochloride [29868-97-1]; Up 200; 9.4uM; PC3; HT_HG-U133A

LRP4 ZNF74 STS

7.79e-041992135872_UP
DrugProtoveratrine A [143-57-7]; Up 200; 5uM; PC3; HT_HG-U133A

CD93 ZNF74 STS

7.79e-041992136618_UP
DrugFlurbiprofen [5104-49-4]; Up 200; 16.4uM; MCF7; HT_HG-U133A

CD93 NSD3 STS

7.79e-041992136472_UP
DrugEucatropine hydrochloride [536-93-6]; Down 200; 12.2uM; PC3; HT_HG-U133A

ZNF74 SVEP1 NSD3

7.79e-041992134316_DN
DrugAspartic acid, N-acetyl (R,S) [997-55-7]; Up 200; 22.8uM; MCF7; HT_HG-U133A

LAMA2 NSD3 STS

7.79e-041992133265_UP
DrugLobeline alpha (-) hydrochoride [134-63-4]; Down 200; 10.6uM; PC3; HT_HG-U133A

ZNF74 NID2 STS

7.79e-041992135784_DN
DrugUngerine nitrate; Up 200; 10.2uM; MCF7; HT_HG-U133A

CD93 LRP4 SVEP1

7.79e-041992136076_UP
DrugFelbinac [5728-52-9]; Up 200; 18.8uM; MCF7; HT_HG-U133A

LRP4 STS ZNF646

7.90e-042002133398_UP
Diseasesevere acute respiratory syndrome, COVID-19

TNR MEGF11 EYS

4.29e-03447223EFO_0000694, MONDO_0100096

Protein segments in the cluster

PeptideGeneStartEntry
SHHCFNTAGSFTCGC

EGFL8

156

Q99944
SLCFNTQGSFHCGCL

CD93

441

Q9NPY3
GKCTCRTGFTGQHCE

MEGF11

766

A6BM72
EGFCQKSAHGFTCIC

EYS

1091

Q5T1H1
EVGCDCSHTGFGGKF

NRXN2

226

Q9P2S2
CFNTLGGHSCVCVNG

NOTCH3

291

Q9UM47
CTNLAGSFSCTCHGG

NOTCH3

826

Q9UM47
SCHCKTGFGGVSCDR

LAMA2

441

P24043
TGFCCHCQSKFYGNG

NID2

506

Q14112
GTGCFLLCNTGHKCV

GK

286

P32189
SSCCISGFGGHCSLV

LCE7A

46

P0DV60
KCSGFHSCFTCACGQ

FAM221A

146

A4D161
SQGCFCAGCSRQIGF

PLEKHM1

826

Q9Y4G2
GVFHCCTFCSSGGQK

TRIM45

506

Q9H8W5
VGSNGCFATHVCFCF

STS

476

P08842
SFRCLCAAGFTGSHC

SVEP1

1366

Q4LDE5
GFGHATAGKCTSTCQ

SLCO4A1

561

Q96BD0
HGCSVCGKAFSTKFS

ZNF615

316

Q8N8J6
SGHGNFSFESCGCIC

TNR

176

Q92752
QTGHFGCQACSKGFS

ZNF646

1226

O15015
TECHCGADNCSGFLG

NSD3

1271

Q9BZ95
CGECGKAFSCHSSLN

ZNF74

306

Q16587
ACGVNNGGCTHLCFA

LRP4

1616

O75096